Description
The abstract describes optogenetics as revolutionary for probing neural circuits but doesn’t address potential adverse effects of repeated light stimulation or chronic opsin expression. Understanding safety profiles is critical for translating optogenetic approaches to therapeutic applications in neurological disorders.
Gap type: open_question Source paper: Making Sense of Optogenetics. (2015, The international journal of neuropsychopharmacology, PMID:26209858)
Evidence summary
Resolved by hypothesis h-var-e2b5a7e7db: GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance. Score: 0.964. Supporting PMIDs: 19449329, 23431156, 26282667, 40994429, 40796363.